Cost-Effectiveness of Biologics in Early Rheumatoid Arthritis

被引：6
|
作者：
Finckh, Axel [1 ]
Bansback, Nick [2 ]
Liang, Matthew H. [3 ]
机构：
[1] Univ Hosp Geneva, CH-1205 Geneva, Switzerland
[2] Univ British Columbia, St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada
[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2010年 / 152卷 / 05期
关键词：
THERAPY;
D O I：
10.7326/0003-4819-152-5-201003020-00018
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：333 / 334
页数：2
相关论文
共 50 条
  • [1] Cost-Effectiveness of Biologics in Early Rheumatoid Arthritis RESPONSE
    Boers, Maarten
    ANNALS OF INTERNAL MEDICINE, 2010, 152 (05) : 334 - 334
  • [2] The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review
    Joensuu, Jaana T.
    Huoponen, Saara
    Aaltonen, Kalle J.
    Konttinen, Yrjo T.
    Nordstrom, Dan
    Blom, Marja
    PLOS ONE, 2015, 10 (03):
  • [3] Cost effectiveness of biologics in the treatment of rheumatoid arthritis
    Müller-Ladner, U
    INTERNIST, 2004, 45 (12): : 1402 - 1406
  • [4] Cost-Effectiveness of Early Treatment with Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients with Established Rheumatoid Arthritis
    Dipen Patel
    Ahmed Shelbaya
    Raymond Cheung
    Jyoti Aggarwal
    Sang Hee Park
    Javier Coindreau
    Advances in Therapy, 2019, 36 : 2086 - 2095
  • [5] Cost-Effectiveness of Early Treatment with Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients with Established Rheumatoid Arthritis
    Patel, Dipen
    Shelbaya, Ahmed
    Cheung, Raymond
    Aggarwal, Jyoti
    Park, Sang Hee
    Coindreau, Javier
    ADVANCES IN THERAPY, 2019, 36 (08) : 2086 - 2095
  • [6] Cost-Effectiveness of Biologics Compared with Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Patel, Aarat M.
    Lupash, Daniel
    Chew, Douglas
    Levesque, Marc C.
    Moreland, Larry W.
    CURRENT RHEUMATOLOGY REPORTS, 2011, 13 (05) : 381 - 382
  • [7] MODELLING THE COST-EFFECTIVENESS OF FIRST-LINE BIOLOGICS FOR RHEUMATOID ARTHRITIS IN ENGLAND AND WALES
    Righetti, C.
    Lebmeier, M.
    Pennington, B.
    Brereton, N. J.
    VALUE IN HEALTH, 2013, 16 (07) : A578 - A579
  • [8] Cost-Effectiveness of Biologics as First-Line Treatment of Rheumatoid Arthritis: Case Closed?
    Boers, Maarten
    ANNALS OF INTERNAL MEDICINE, 2009, 151 (09) : 668 - 669
  • [9] Cost-Effectiveness of Biologics Compared with Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Aarat M. Patel
    Daniel Lupash
    Douglas Chew
    Marc C. Levesque
    Larry W. Moreland
    Current Rheumatology Reports, 2011, 13 : 381 - 382
  • [10] Cost effectiveness of biologics for rheumatoid arthritis: A systematic review
    Pham, B.
    McMartin, K.
    Bornstein, M.
    Machado, M.
    Bombardier, C.
    Krahn, M. D.
    Levin, L.
    VALUE IN HEALTH, 2008, 11 (03) : A258 - A258
12345